Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates
- 13 October 2009
- Vol. 28 (2) , 494-511
- https://doi.org/10.1016/j.vaccine.2009.09.133
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccinationThe Journal of Experimental Medicine, 2008
- Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaVaccine, 2007
- Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 proteinVirology, 2007
- Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challengeVirology, 2007
- Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB ProteinsClinical and Vaccine Immunology, 2007
- Smallpox subunit vaccine produced in planta confers protection in miceProceedings of the National Academy of Sciences, 2007
- Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesVaccine, 2007
- Alphavirus replicon approach to promoterless analysis of IRES elementsVirology, 2006
- Ligand-induced and nonfusogenic dissolution of a viral membraneProceedings of the National Academy of Sciences, 2006
- Mutations in the E2 Glycoprotein of Venezuelan Equine Encephalitis Virus Confer Heparan Sulfate Interaction, Low Morbidity, and Rapid Clearance from Blood of MiceVirology, 2000